Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Hypertrophic Cardiomyopathy
100%
Myocardial Disease
50%
Cardiology
50%
Heart Left Ventricle Outflow Tract Obstruction
50%
Mavacamten
50%
Cardiovascular Risk
50%
Myocarditis
50%
New York Heart Association Class
30%
Ventricular Outflow Tract
29%
Degree Relative
25%
Maintenance Drug Dose
21%
Biological Marker
14%
Family History
8%
Atrial Fibrillation
8%
Left Ventricular Diastolic Dysfunction
8%
Left Ventricular Hypertrophy
8%
Prevalence
8%
Diabetes
8%
Systolic Dysfunction
8%
Apoplexy
8%
Body Mass Index
8%
Sarcomere
8%
Myocardium
7%
CYP2C19
7%
Treatment Interruption
7%
Congestive Heart Failure
7%
Hypertrophic Obstructive Cardiomyopathy
7%
Targeted Therapy
7%
Heart Ventricle Ejection
7%
Care Pathway
7%
Clinical Pathway
7%
Clinical Assessment
7%
Pharmacology, Toxicology and Pharmaceutical Science
Hypertrophic Cardiomyopathy
100%
Myocarditis
50%
Cardiovascular Risk
50%
Myocardial Disease
50%
Mavacamten
50%
Heart Left Ventricle Outflow Tract Obstruction
50%
Maintenance Dose
21%
Biological Marker
14%
Systolic Dysfunction
8%
Cerebrovascular Accident
8%
Atrial Fibrillation
8%
Heart Left Ventricle Hypertrophy
8%
Prevalence
8%
Left Ventricular Diastolic Dysfunction
8%
Hypertrophic Obstructive Cardiomyopathy
7%
Congestive Heart Failure
7%
CYP2C19
7%